New Products

EL SEGUNDO, Calif. — Murad has announced the debut of Pore Reform, a skin care regimen that includes a Blackhead & Pore Clearing Duo to unclog and seal pores, shielding the skin from blackhead-causing dirt and debris.

Featuring Oxidation Reversal Complex, proprietary technology that helps reverse and prevent sebum oxidation, Blackhead & Pore Clearing Duo is clinically proven to reduce the formation of blackheads by an average of 58%, the company stated.

HOLZKIRCHEN, Germany — Sandoz has started a late-stage clinical trial of a biosimilar version of a drug used to treat autoimmune disorders, hoping the results will support its efforts to win regulatory approval in the United States and Europe.

Sandoz, the generics arm of Swiss drug maker Novartis, said it had started a phase-3 trial of biosimilar etanercept, a knock-off version of Amgen's Enbrel, used to treat chronic plaque-type psoriasis.

NEW YORK — The Food and Drug Administration has approved a gel formulation of a foot fungus drug made by Merz Pharmaceuticals, according to published reports.

According to reports, the FDA approved a gel formulation of Merz's Naftin (naftifine), used to treat athlete's foot, known medically as tinea pedis.

A cream version of the drug is already approved, and the latest approval was based on two clinical trials of more than 1,700 patients, according to reports.

HENDERSONVILLE, N.C. — GutZgray has developed a new line of hair products to care for gray hair or colored gray hair. 

The manufacturer will be highlighting the new product at the Cosmoprof North America Conference in July in Las Vegas. Company representatives will be located in Booth D11042.

These gray hair products are designed specifically to nurture and invigorate gray hair, which tends to be coarser than hair that retains natural color.

PRINCETON, N.J. — Sandoz has launched a generic topical drug for rosacea, the drug maker said Tuesday.

Sandoz, the generics division of Swiss drug maker Novartis, announced the launch of metronidazole 1% topical gel, calling it the first generic version of Galderma Labs' Metrogel. The drug is indicated for treating inflammatory lesions of rosacea, estimated to affect about 16 million Americans.

Metrogel had sales of about $110 million during the 12-month period that ended in April, according to IMS Health.

OMAHA, Neb. — To address pet behavior issues, Sergeant's Pet Care Products has created a new product called Vetscription PetStop! behavior correction spray for dogs and cats that is available now at Walmart stores nationwide.

NEW YORK — Rally Labs recently introduced its Blowfish for Hangovers, a morning-after remedy that has a bit of a cult following in New York, into the drug channel the company noted. 

The Blowfish formulation contains a combination of aspirin and caffeine in an effervescent tablet specifically formulated for hangovers. The buffered formula helps rehydrate, restore alertness and provide relief for a headache, Rally Labs noted. 

MOUNTAIN VIEW, Calif. — A drug for treating obesity has become available through a network of about 8,000 retail pharmacies around the country, the drug's manufacturer said Monday.

Vivus said the drug, Qsymia (phentermine; topiramate) extended-release capsules would be available at Costco and Walgreens stores, including Duane Reade stores. The launch is happening ahead of the previously announced mid-July launch date.